(Siegel et al., 2018) Most of the patients diagnosed with NSCLC are already in advanced stages for which effective treatment options are still lacking (Hayden and Ghosh, 2008; Saha et al., 2020) LINC00467 regulates ERK1/2 signaling in NSCLC. This evidence concerns the gene MAPK3 and non-small cell lung carcinoma.